Life sciences is the one marketing category where the review process, not the creative, decides how much the work costs and how long it takes. A campaign for a regulated product passes through medical, legal and regulatory review before anything is published, and every claim has to be substantiated and consistent with the approved labelling. An agency that has never worked inside that process will produce beautiful assets that never ship. An agency that has will structure the work so review is predictable rather than a series of surprises. Whether you are a diagnostics company selling to laboratory directors, a device maker selling to hospital purchasing committees or a biotech building recognition ahead of a launch, the first thing to establish about any candidate is how they handle review, because everything else follows from it.
The audiences are different businesses, and agencies blur them
Three buyers sit under the same heading and they need almost unrelated work. Selling to clinicians and laboratory directors means peer credibility, published evidence, congress presence and content that survives scrutiny by people who read primary literature for a living. Selling to hospital or health system purchasing means committees, budget cycles, procurement documentation and long relationship building rather than lead capture. Selling to patients or consumers, where that is permitted for the product in question, means an entirely different regulatory footing: the FDA's own explanation of prescription drug advertising sets out the categories of ads and what each must carry, and the requirements in 21 CFR 202.1 govern how risk information is presented. A candidate who pitches the same content programme to all three has not understood the sector. Ask which of the three they have actually delivered, and ask to see the review trail rather than the finished asset.
What regulated review does to timelines and cost
In an unregulated sector, a blog post is written, checked and published in a week. In life sciences the same asset may need referencing to source literature, a claims matrix mapping every assertion to substantiation, review by medical and regulatory, revision, and re-review, and the calendar cost of that cycle is usually longer than the production. This is why credible agencies in this space price differently: fewer assets, more time per asset, and explicit allowance for review rounds in the scope. When you receive a proposal, look for the number of review rounds included and what happens when you exceed them. A quote that includes unlimited revisions in a regulated category is either mispriced or written by someone who has never been through submission. The FTC's health products compliance guidance is a useful reference for the substantiation standard that applies to health claims generally, and it is worth agreeing early who inside your organisation owns that standard.
Search and web work still matters, and is where most budgets sit
Scientific buyers research before they ever speak to a representative, and the searches they run are specific: assay names, catalogue numbers, indications, comparison of methods, regulatory pathway questions. That specificity is an advantage. The volumes are low but the intent is enormous, and technical pages written by people who understand the science outrank general marketing content easily because so little good material exists. The practical work is unglamorous: a product page per catalogue item that is actually indexed, technical documentation that is crawlable rather than locked in unreadable files, and application notes that answer a real experimental question. Buying digital marketing and seo services for a life sciences company should mean this kind of technical page work rather than a generic content calendar, and the fastest way to tell the two apart is to ask a candidate which specific searches they would target and why.
How to vet a candidate agency on evidence
Ask for named clients in your segment and check the work is still live. Ask who writes the science: whether the agency employs people with relevant degrees, uses contracted subject matter experts, or hands technical writing to generalists with a template. Ask how they handle promotional review, whether they have worked inside a client's review system, and how many rounds they budget. Ask what happens to your website, analytics, domain and content if the relationship ends, and get the answer in the contract. Then ask the two questions that thin a shortlist fastest: what is the smallest engagement you accept and what is the minimum term. Finally, ask what they would decline to do at your budget. In a sector where the constraint is review capacity rather than ideas, a candidate who cannot name something they would refuse is selling a package rather than a plan.
Questions people ask about digital marketing life sciences
Do we need an agency that specialises in life sciences?
For anything that touches promotional review or regulated claims, yes, because the cost of a generalist is measured in rejected assets and lost quarters rather than in fees. For work that sits away from the product, such as recruitment marketing or corporate website infrastructure, a strong generalist with good process can be a better buy. Split the scope accordingly rather than paying specialist rates for everything.
How should results be measured when the sales cycle is very long?
Not by leads alone. Useful intermediate measures include qualified enquiries from target account lists, requests for technical documentation, sample or demo requests, and congress meeting bookings attributable to campaigns. Agree the definitions in writing before the first month, because in a long cycle the definition is the whole argument.
Can our regulatory team review agency content quickly enough?
That is a capacity question about your organisation, not the agency, and it is the most common reason programmes stall. Establish how many assets your reviewers can genuinely process a month before you commission a content plan, then size the plan to that number rather than to what an agency proposes.
Is paid search useful for a regulated product?
Often yes for unbranded disease awareness, technical searches and recruitment, and much more constrained for branded promotion depending on the product and jurisdiction. Ask candidates to show which campaign types they have run for a comparable product and how the ad copy was reviewed and approved.